abstract |
The present invention provides an antibody construct comprising a first human binding domain capable of binding to human CDH19 on the surface of a target cell and a second domain capable of binding to human CD3 on the surface of the T cell. Furthermore, the present invention relates to a nucleic acid sequence encoding said antibody construct, a vector comprising said nucleic acid sequence, and a host cell transformed or transfected with said vector. In addition, the present invention relates to a method of producing an antibody construct of the invention, a medical use of said antibody construct, and a kit comprising said antibody construct. |